BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37511344)

  • 1. High CD142 Level Marks Tumor-Promoting Fibroblasts with Targeting Potential in Colorectal Cancer.
    Soós AÁ; Kelemen A; Orosz A; Szvicsek Z; Tölgyes T; Dede K; Bursics A; Wiener Z
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
    Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
    Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
    Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
    Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
    Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal fibroblasts shape the myeloid phenotype in normal colon and colorectal cancer and induce CD163 and CCL2 expression in macrophages.
    Stadler M; Pudelko K; Biermeier A; Walterskirchen N; Gaigneaux A; Weindorfer C; Harrer N; Klett H; Hengstschläger M; Schüler J; Sommergruber W; Oehler R; Bergmann M; Letellier E; Dolznig H
    Cancer Lett; 2021 Nov; 520():184-200. PubMed ID: 34256095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer-associated fibroblast (CAF) secretomes-induced epithelial-mesenchymal transition on HT-29 colorectal carcinoma cells associated with hepatocyte growth factor (HGF) signalling.
    Wanandi SI; Hilbertina N; Siregar NC; Abdullah M; Jeo WS
    J Pak Med Assoc; 2021 Feb; 71(Suppl 2)(2):S18-S24. PubMed ID: 33785936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1246 shuttling from fibroblasts promotes colorectal cancer cell migration.
    Si G; Li S; Zheng Q; Zhu S; Zhou C
    Neoplasma; 2021 Mar; 68(2):317-324. PubMed ID: 33231089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Associated Fibroblast Risk Model for Prediction of Colorectal Carcinoma Prognosis and Therapeutic Responses.
    Wang Y; Chen Z; Zhao G; Li Q
    Mediators Inflamm; 2023; 2023():3781091. PubMed ID: 37144239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
    Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
    Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
    Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
    Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B.
    Zhu HF; Zhang XH; Gu CS; Zhong Y; Long T; Ma YD; Hu ZY; Li ZG; Wang XY
    Cancer Biol Ther; 2019; 20(7):967-978. PubMed ID: 30894065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of ADAM9.
    Ao T; Mochizuki S; Kajiwara Y; Yonemura K; Shiraishi T; Nagata K; Shinto E; Okamoto K; Nearchou IP; Shimazaki H; Kishi Y; Okada Y; Ueno H
    Int J Cancer; 2022 May; 150(10):1706-1721. PubMed ID: 35080810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP, a novel target regulates F-actin rearrangement-associated CAFs transformation and promotes colorectal cancer cell progression.
    Naktubtim C; Payuhakrit W; Uttarawichien T; Hassametto A; Suwannalert P
    Biomed Pharmacother; 2022 Nov; 155():113757. PubMed ID: 36271545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR4/TGF-β1 mediated hepatic stellate cells differentiation into carcinoma-associated fibroblasts and promoted liver metastasis of colon cancer.
    Tan HX; Gong WZ; Zhou K; Xiao ZG; Hou FT; Huang T; Zhang L; Dong HY; Zhang WL; Liu Y; Huang ZC
    Cancer Biol Ther; 2020; 21(3):258-268. PubMed ID: 31825725
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer-associated fibroblasts secrete Wnt2 to promote cancer progression in colorectal cancer.
    Aizawa T; Karasawa H; Funayama R; Shirota M; Suzuki T; Maeda S; Suzuki H; Yamamura A; Naitoh T; Nakayama K; Unno M
    Cancer Med; 2019 Oct; 8(14):6370-6382. PubMed ID: 31468733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbiased differential proteomic profiling between cancer-associated fibroblasts and cancer cell lines.
    Lau R; Yu L; Roumeliotis TI; Stewart A; Pickard L; Riisanes R; Gurel B; de Bono JS; Choudhary JS; Banerji U
    J Proteomics; 2023 Sep; 288():104973. PubMed ID: 37481068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Function of a Disintegrin and Metalloproteinases in Cancer-Associated Fibroblasts of Colorectal Cancer.
    Mochizuki S; Ao T; Sugiura T; Yonemura K; Shiraishi T; Kajiwara Y; Okamoto K; Shinto E; Okada Y; Ueno H
    Digestion; 2020; 101(1):18-24. PubMed ID: 31722362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases.
    Giguelay A; Turtoi E; Khelaf L; Tosato G; Dadi I; Chastel T; Poul MA; Pratlong M; Nicolescu S; Severac D; Adenis A; Sgarbura O; Carrère S; Rouanet P; Quenet F; Ychou M; Pourquier D; Colombo PE; Turtoi A; Colinge J
    Theranostics; 2022; 12(17):7624-7639. PubMed ID: 36438498
    [No Abstract]   [Full Text] [Related]  

  • 19. Bufalin reverses cancer-associated fibroblast-mediated colorectal cancer metastasis by inhibiting the STAT3 signaling pathway.
    Wang H; Chen J; Li S; Yang J; Tang D; Wu W; Yu K; Cao Y; Xu K; Yin P; Chen Y; Li W
    Apoptosis; 2023 Apr; 28(3-4):594-606. PubMed ID: 36705874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
    Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
    J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.